Pharm Plan Agenda 2014.10.29

09:00 - 09:15 Welcome

• Participants
• Review and Approve Agenda

09:15 - 10:45 Medication Treatment

• Proposal

• ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_MedicationTreatment_v1.docx

• Vision of the work ahead (Jürgen, Stephane)

• ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTherapy/MedicationTherapy%20Vision%2020141023.pptx

• Discussion
• Formal approval of the new work-item proposal
• Defining next steps

11:00 - 12:30 Pharmacy Administration

• Current work:

• ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration

• Wrapping up work done so far, open issues and how to continue (Jürgen)

• ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration/Administration%20Issues%20and%20Thoughts%2020141023.pptx

• Discussion
• Defining next steps

13:30 - 14:00 Several Community Pharmacy related issues

• PADV issue: Deep analysis of code "CHANGE" revealed that it actually means "CHANGE + OK" (= implies the OK too). Related to that, the state "OK" actually means "(Unchanged) OK"

• Question: Do we need a simple "CHANGE" which does not also imply the OK? Not needed for A, SA and CH -> at the moment it is an academic discussion

• DIS issue: The Dispenser also needs Profession and Specialty

• Proposal: Exchange <performer> by <author> for the Dispenser. Change <author> by a second <author> for a possible prescriber of the underlying prescription

• PADV issue: Requirement of CH: Providing comments to PRE or DIS items (e.g. The patient has problems swallowing the pill because it's too big).

• Possible solution: Extend PADV by a new code "COMMENT", which has no effect on the workflow, but just provides commenting information, e.g. as concern

• PRE issue: Precondition is often used to describe dosage related information (e.g. "Take on demand")

• Question: Shall it be moved under "Dosage instructions"?

• PADV, PML issue: The issue appears only, when a PRE entry is referenced in a PADV or embedded in a PML + this entry contains an internal reference in the "Reason" element (e.g. to a diagnosis expressed in an Active Problems section)

• Current solution in PADV: The section referenced is not included and instructions are given how to break the internal reference
• Proposed solution: CP on PADV and PML to allow 0..* additional sections to be added in order not to break the internal references. Those section do NOT belong to the PADV/PML document itself, but are just inserted to fulfill the internal reference

• PML issue: CH brought up that the PML might be used for "feeding" a medication plan

• Discussion: Currently PML is intended as a "read-only", on-demand document. Shall that be changed? Should we add a note somewhere to clarify?

14:00 - 15:15 ISO liaison

• Report on ISO meeting in Berlin (Jürgen)
• Commenting on ISO/DIS 17523 "Requirements for electronic prescriptions"

• ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Other/ISO%2017523%20ePrescriptions
• Comments received by Leonidas, Jose, Jürgen
• Defining next steps

• ISO DTS 19293 "Requirements for the record of Dispense Medicinal Products"

• Discussion
• Defining next steps

• ISO/DTS 17251, "Business requirements for the exchange of structured dose instructions for medicinal products"

• Discussion
• Defining next steps

15:30 - 16:30 Hospital-Community Use Cases Whitepaper

• Discussion

• Can it be published? Open issues?

• Defining next steps

16:30 - 17:00 Schedule

• Current version:

• ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Schedule/Schedule_2014-2015_v0.4.doc

• Open issues:

• Status of IHE Joint meeting with ITI, PCC and QRPH: 24-25 February 2015, ASIP Santé Offices, Paris, France (Jürgen)
• Planning of dedicated technicel TCons to work-items (work-item leaders)

17:00 Adjourn

Pharmacy Planning Committee